{"id":"W4399122701","doi":"10.1016/j.ejcskn.2024.100143","title":"A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastatic or unresectable melanoma (RELATIVITY-127)","year":2024,"lang":"en","type":"article","venue":"EJC Skin Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Nivolumab; Medicine; Pharmacokinetics; Safety profile; Metastatic melanoma; Melanoma; Oncology; Pharmacology; Internal medicine; Anesthesia; Adverse effect; Cancer; Immunotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006042274,0.0002368681,0.0006409796,0.0002949272,0.00006263816,0.00002685571,0.0001780083,0.00007939409,0.00211296],"category_scores_gemma":[0.0001856467,0.000163056,0.0000838958,0.001290655,0.000178901,0.00007536758,0.0001252217,0.0005339974,0.000005330889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003520616,"about_ca_system_score_gemma":0.0005292472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001828196,"about_ca_topic_score_gemma":0.00124887,"domain_scores_codex":[0.9975339,0.0004328877,0.0006153131,0.0004135872,0.0006435452,0.0003608315],"domain_scores_gemma":[0.9984207,0.0007574382,0.0001546412,0.0004081589,0.0001659493,0.00009310001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09090069,0.03446618,0.01834104,0.005805597,0.004034693,0.003871156,0.05347608,0.001079075,0.1237308,0.0002374191,0.002464697,0.6615926],"study_design_scores_gemma":[0.3500471,0.1224494,0.09860052,0.009587429,0.007848847,0.003379014,0.006814342,0.1774182,0.2055324,0.0005311699,0.01555166,0.00223988],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907767,0.003741771,0.0000135289,0.0003270212,0.0001772357,0.003828067,0.00009758585,0.00003967454,0.0009983763],"genre_scores_gemma":[0.9924011,0.001150511,0.00004414492,0.00002091577,0.0000424457,0.0001403111,0.00002536487,0.00005601863,0.006119245],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6593527,"threshold_uncertainty_score":0.9987993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02617570707622666,"score_gpt":0.3528993156838462,"score_spread":0.3267236086076196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}